 Home </wps/find/homepage.cws_home> | Site map
</wps/find/sitemap.cws_home/sitemap> | Elsevier websites
</wps/find/elsevierwebsites.cws_home/elsevierwebsites> | Alerts
</wps/find/home_content.cws_home/alertingservices>
	Elsevier 		

	Product information search 	
	Search all Elsevier sites 	
Search <javascript:submitSearchForm(document.forms['searchForm'])> 	
Advanced Product Search
</wps/find/advproductsearch.cws_home?action=product_search&search=no>

	

Go to Elsevier home page </wps/find/homepage.cws_home>

	
	Products
</wps/find/subject_area_browse.cws_home/?sh1State=-null-SAR-SAA-SAC-SAD-SAF-SA1-SAI-SAJ-SAK-SAQ-SAP-SAB-SAE-SAL-SAN-SAO-SAG-SAH-SAM&sh2State=&allParents=y&showAll=y>
	

	Gene Expression Patterns
</wps/find/journaldescription.cws_home/628039/authorinstructions?navopenmenu=-2>
	

	Journal information

	Product description
</wps/find/journaldescription.cws_home/628039/description#description> 	

	Editorial board
</wps/find/journaleditorialboard.cws_home/628039/editorialboard#editorialboard>
	

	Audience </wps/find/journalaudience.cws_home/628039/description#audience> 	

	Abstracting/indexing
</wps/find/journalabstracting.cws_home/628039/abstracting#abstracting> 	

	Subscription information

	Bibliographic and ordering information
</wps/find/journalbibliographicinfo.cws_home/628039/description#bibliographicinfo>
	

	Combined subscriptions
</wps/find/journalcombinedsubscriptions.cws_home/628039/description#combinedsubscriptions>
	

	Conditions of sale
</wps/find/journalconditionsofsale.cws_home/628039/conditionsofsale#conditionsofsale>
	

	Dispatch dates
</wps/find/journaldispatchdates.cws_home/628039/dispatchdates#dispatchdates>
	

	Journal-related information

	Contact the publisher
</wps/find/journalcontactpublisher.cws_home/628039/contactpublisher#contactpublisher>
	

	Impact factor
</wps/find/journalimpactfactors.cws_home/628039/description#impactfactors> 	

	Most downloaded articles
<javascript:openWindow("http://top25.sciencedirect.com/?journal_id=1567133X","topdownload")>
	

	Other journals in same subject area
</wps/find/products_in_subject_and_group.cws_home/628039> 	

	Related publications
</wps/find/journalrelatedpublications.cws_home/628039/relatedpublications#relatedpublications>
	

	Support & contact </wps/find/supportfaq.cws_home/overview> 	

	About Elsevier </wps/find/intro.cws_home/ataglance> 	

	Select your view
</wps/find/journaldescription.cws_home/628039/authorinstructions?navopenmenu=4>
	

	

			
	
	GENE EXPRESSION PATTERNS	
		
	

*Guide for Authors*

*Instructions to authors for /Gene Expression Patterns/ *

*Types of papers*
The journal is devoted to the rapid publication of high quality "cloning
and expression" papers, papers reporting patterns of expression of
interesting or important genes during development, the activity of
regulatory regions directing specific gene expression to particular
systems and/or the results of molecular or gene expression screens
analysing interesting developmentally-relevant events or stages.
_ *Please note* _ that the standards for acceptance of these papers have
gone up substantially - *we expect papers to be truly thorough and
complete and either cover the expression of a gene at many different
stages of development (making it unlikely that a subsequent paper will
be needed to describe the expression of the gene), or compare several
different genes during development of a particular organ system or in
many different species, or report the results of an in situ screen or a
thorough analysis of gene regulatory regions. A single gene expression
pattern in a single organ system is rarely acceptable unless it is of
_very high_ intrinsic interest.*


*Submission of papers*

Submission to this journal must be made on-line, which greatly speeds up
the review and publication processes. Use the following guidelines to
prepare your article. Via the homepage of this journal (External link
http://www.elsevier.com/journals), you will be guided stepwise through
the creation and uploading of the various files. Once the uploading is
done, our system automatically generates an electronic (PDF) proof,
which is then used for reviewing. All correspondence, including
notification of the Editor's decision and requests for revisions, will
be by e-mail.

Prior to submitting your manuscript on-line you should have prepared:
• a Word document of the full text (including a title page containing
authors' addresses, email and FAX number of the corresponding author, a
second page with the abstract and the full text of the manuscript
including references and figure legends).
Checklist for colour Figures:
• The figures should be 1000 dpi (min. 300dpi)
• The figures must be in TIFF format
• The figures should be the correct size so that no reduction or
enlargement has to be carried out. If this is not possible it is better
if the figures are sent 'too large' so that in the reduction process the
colour detail will not be lost.

The sections below explain how manuscripts should be organised and other
details.

*Submission checklist*

It is hoped that this list will be useful during the final checking of
an article prior to sending it to the journal's Editors for review.
Please consult this Guide for Authors for further details of any item.

*Ensure that the following items are present:*
• One Author designated as corresponding Author:
• E-mail address
• Full postal address
• Telephone and fax numbers
• All necessary files have been uploaded
• Keywords
• All figure captions
• All tables (including title, description, footnotes)

*Further considerations*
• Manuscript has been "spellchecked". If you are not a fluent English
speaker it is advisable to consult a native speaker for polishing the
manuscript
• references are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text,
and vice versa
• Permission has been obtained for use of copyrighted material
(including material from the Web), both from the authors (if available)
and from the copyright owner.

*Language Editing:*
International Science Editing and Asia Science Editing can provide
English language and copyediting services to authors who want to publish
in scientific, technical and medical journals and need assistance
/before/ they submit their article or, /before/ it is accepted for
publication. Authors can contact these services directly: International
Science Editing External link
(http://www.internationalscienceediting.com) and Asia Science Editing
External link (http://www.asiascienceediting.com) or, for more
information about language editing services, please contact
authorsupport@elsevier.com <mailto:authorsupport@elsevier.com> who will
be happy to deal with any questions.

Please note Elsevier neither endorses nor takes responsibility for any
products, goods or services offered by outside vendors through our
services or in any advertising. For more information please refer to our
terms and conditions (External link
http://www.elsevier.com/termsandconditions).

*For any further information please contact the Author Support
Department at authorsupport@elsevier.com.*

*Organisation of the manuscript*

The text should begin with a cover page with the manuscript title and
listing all authors and contact details of the corresponding author as
well as a list of up to 40 key words (a larger number of key words will
increase the chances that your manuscript will be found through Medline
and other databases). This should be followed by a page containing an
abstract of up to 250 words.
The general organisation of the text should be similar to that of a
/Nature/ letter, with the whole text in a single main section headed "1.
Results and Discussion" (this may be subdivided into sub-sections eg.:
"1.1 Expression of Wnt92 in the nervous system"). There should be no
separate introductory section, but the text may begin with one or more
introductory paragraphs briefly explaining why the study was undertaken
and its expected significance. A brief concluding paragraph or section
highlighting the important and/or novelty of the results obtained may be
included.
After the main text, the second section should be headed "2.
Experimental Procedures" (which may also be subdivided into sub-sections
2.1, 2.2, etc.), followed by "3. Acknowledgements" (if appropriate),
"References" and "Figure Legends".
Nomenclature, reference system, etc., are the same as those adopted by
the major cell/developmental biology journals (e.g., /Cell,
Developmental Cell, The EMBO Journal/).

*References*

Responsibility for the accuracy of bibliographic citations lies entirely
with the Authors.

/Citations in the text/: Please ensure that every reference cited in the
text is also present in the reference list (and vice versa). The
abstract should not contain references unless absolutely essential; any
such references must be given in full within the text of the abstract
and will be included in the 250 word limit. Unpublished results and
personal communications should not be in the reference list, but may be
mentioned in the text (personal communications only with the express
consent of the communicator) if they are essential.

/Citing and listing of Web references./ As a minimum, the full URL
should be given. Any further information, if known (Author names, dates,
reference to a source publication, etc.), should also be given.

/Text:/ All citations in the text should refer to:
1. /Single Author/: the Author's name (without initials, unless there is
ambiguity) and the year of publication;
3. /Two Authors/: both Authors' names and the year of publication;
3. /Three or more Authors/: first Author's name followed by "et al." and
the year of publication.
Citations may be made directly (or parenthetically). Groups of
references cited together (within one set of parentheses) should be
listed first chronologically (ie. the oldest reference first), then
alphabetically.

Examples: "... as previously demonstrated (Jones, 1995; Allan, 1996a,
1996b, 1999). Kramer et al. (2000) have recently shown ...."

/List/: References should be arranged first alphabetically and then
further sorted chronologically if necessary. More than one reference
from the same author combination in the same year must be identified by
the letters "a", "b", "c", etc., placed after the year of publication.

/Examples:/

Reference to a journal publication:

Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2000. The art of
writing a scientific article. J. Sci. Commun. 163, 51-59.

Reference to a book:

Strunk Jr., W., White, E.B., 1979. The Elements of Style, third ed.
Macmillan, New York.

Reference to a chapter in an edited book:

Mettam, G.R., Adams, L.B., 1999. How to prepare an electronic version of
your article, in: Jones, B.S., Smith , R.Z. (Eds.), Introduction to the
Electronic Age. E-Publishing Inc., New York, pp. 281-304.

*Preparation of electronic illustrations *

Submitting your artwork in an electronic format helps us to produce your
work to the best possible standards, ensuring accuracy, clarity and a
high level of detail.

Checklist for colour Figures:
• The figures should be 1000 dpi (min. 300dpi)
• The figures may be in either RGB or CMYK format. If supplying in RGB
format please check the typeset proof carefully to ensure the conversion
is accurate.
• The figures must be in TIFF format
• The figures should be the correct size so that no reduction or
enlargement has to be carried out. If this is not possible it is better
if the figures are sent 'too large' so that in the reduction process the
colour detail will not be lost

General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics" or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier,
Helvetica, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files (Fig. 1, Fig.
2, etc.), and supply a separate listing of the files and the software used.
• Provide captions to illustrations separately, at the end of the text.
• Produce images near to the desired size of the printed version.

A detailed guide on electronic artwork is available on our website:
For more detailed instructions please visit our artwork instruction
pages at External link http://www.elsevier.com/artworkinstructions

*Colour figures*

The cost of colour reproduction will not be charged to the author.
However, the decision to publish figures in colour will be left to the
Editors' discretion.

*Materials*

Publication of a research article in /Gene Expression Patterns: a
section of MOD/ is taken to imply that the authors are prepared to
distribute all non-commercially obtained materials used in the
experiments (e.g. cells, DNA, antibodies, primary data), to other
academic researchers for their own use or for verification. All nucleic
acid and protein sequences must have been deposited in the appropriate
databases and the Accession Numbers cited in the paper.

/For each and every/ accession number cited in an article, Authors
should type the accession number in * _bold, underlined text_.* Letters
in the accession number should always be capitalised. This combination
of letters and format will enable Elsevier's typesetters to recognise
the relevant texts as accession numbers and add the required link to the
GenBank sequences.

*Data from microarray and other similar screens*

Please see the MGED open letter specifying microarray standards at
http://www.mged.org/Workgroups/MIAME/miame_checklist.html. Authors
submitting manuscripts relying on microarray or similar screens must
supply the data as Supplementary data (see below) at the time of
submission, along with the completed MIAME checklist. The data must be
MIAME-compliant and supplied in a form that is widely accessible. The
microarray data must also be submitted to either the GEO
(http://www.ncbi.nlm.nih.gov/geo/) or ArrayExpress
(http://www.ebi.ac.uk/arrayexpress/) databases, with accession numbers
at or before acceptance of the paper for publication.
The editors understand that on occasion authors may not feel it
appropriate to deposit the entire data set at the time of publication of
this paper. We are therefore willing to consider exceptions to this
requirement in response to a request from the authors, which must be
made at the time of initial submission or as part of an informal
pre-submission enquiry.

*Mouse Gene Expression Data*

Upon acceptance of the manuscript for publication in MODGEP, authors
reporting mouse gene expression data from RNA in situ hybridization,
immunohistochemistry, Northern blot, Western blot and RT-PCR experiments
are requested to submit pertinent data to the Mouse Gene Expression
Database (GXD). These data submissions will receive accession numbers
that may then be inserted into the manuscript. Please see GXD's
guidelines for electronic data submission at
http://www.informatics.jax.org/mgihome//GXD/GEN/gxd_submission_guidelines.shtml
.

*Supplementary data*

Elsevier now accepts electronic supplementary material (e-components) to
support and enhance the published paper. These allow the Author to
publish movies, animation sequences, high-resolution images, data sets
(including microarray data; see above) and more. Supplementary files
supplied will be published online alongside the electronic version of
your article in Elsevier Web products, including ScienceDirect:
http://www.sciencedirect.com. To ensure that your submitted material is
directly usable, please ensure that data is provided in one of our
recommended file formats. Authors should submit the material in
electronic format together with the article and supply a concise and
descriptive caption for each file. For more detailed instructions please
visit our artwork instruction pages at External link
http://www.elsevier.com/artworkinstructions.

*Other important conditions *

It is essential to give a fax number and e-mail address for the
corresponding author when submitting a manuscript. Articles must be
written in good English. Submission of an article implies that the work
described has not been published previously (except in the form of an
abstract or as part of a published lecture or academic thesis), that it
is not under consideration for publication elsewhere, that its
publication is approved by all Authors and tacitly or explicitly by the
responsible authorities where the work was carried out, and that, if
accepted, it will not be published elsewhere in the same form, in
English or in any other language, without the written consent of the
Publisher.

Upon acceptance of an article, authors will be asked to sign a Journal
Publishing Agreement (for more information on this and copyright see
External link http://www.elsevier.com/copyright). Acceptance of the
agreement will ensure the widest possible dissemination of information.
An e-mail (or letter) will be sent to the corresponding author
confirming receipt of the manuscript together with a `Journal Publishing
Agreement form or a link to the online version of this agreement.
If excerpts from other copyrighted works are included, the Author(s)
must obtain written permission from the copyright owners and credit the
source(s) in the article. Elsevier has preprinted forms for use by
Authors in these cases: contact Elsevier's Rights Department, Oxford,
UK: phone (+44) 1865 843830, fax (+44) 1865 853333, e-mail
permissions@elsevier.com. Requests may also be completed on-line via the
Elsevier homepage (http://www.elsevier.com/locate/permissions).

*Ethics of experimentation*

Authors describing investigations in animals or on human tissue must
specify that the research conformed to the stipulations of the
appropriate institutional review body and ethics committee.

*Proofs*

When your manuscript is received by the Publisher it is considered to be
in its final form. Proofs are not to be regarded as "drafts". One set of
page proofs in PDF format will be sent by e-mail to the corresponding
Author, to be checked for typesetting/editing. No changes in, or
additions to, the accepted (and subsequently edited) manuscript will be
allowed at this stage. Proofreading is solely your responsibility.

*Page charges*

/Gene Expression Patterns/ has NO page charges. *25 free reprints* are
supplied per contribution: an additional number may be ordered at the
prices quoted on the order form sent to the corresponding author.*US
National Institutes of Health (NIH) voluntary posting ("Public Access")
policy.*

Elsevier facilitates author response to the NIH voluntary posting
request (referred to as the NIH "Public Access Policy"; see External
link http://www.nih.gov/about/publicaccess/index.htm ) by posting the
author's peer-reviewed manuscript directly to PubMed Central on request
from the author, 12 months after formal publication. Upon notification
from Elsevier of acceptance, we will ask you to confirm via e-mail (by
e-mailing us at NIHauthorrequest@elsevier.com
<mailto:NIHauthorrequest@elsevier.com> that your work has received NIH
funding and that you intend to respond to the NIH policy request, along
with your NIH award number to facilitate processing. Upon such
confirmation, Elsevier will submit to PubMed Central on your behalf a
version of your manuscript that will include peer-review comments, for
posting 12 months after formal publication. This will ensure that you
will have responded fully to the NIH request policy. There will be no
need for you to post your manuscript directly with PubMed Central, and
any such posting is prohibited.

*Policy for Wellcome Trust funded authors*
External link
http://www.elsevier.com/wps/find/authorshome.authors/wellcometrustauthors

*Authors' rights:*

As an author you (or your employer or institution) may do the following:
• make copies (print or electronic) of the article for your own personal
use, including for your own classroom teaching use
• make copies and distribute such copies (including through e-mail) of
the article to research colleagues, for the personal use by such
colleagues (but not commercially or systematically, e.g., via an e-mail
list or list server)
• post a pre-print version of the article on Internet websites including
electronic pre-print servers, and to retain indefinitely such version on
such servers of sites
• post a revised personal version of the final text of the article (to
reflect changes made in the peer review and editing process) on your
personal or institutional website or server, with a link to the journal
homepage (on Elsevier.com)
• present the article at a meeting or conference and to distribute
copies of the article to the delegates attending such a meeting
• for your employer, if the articles is a 'work for hire', made within
the scope of your employment, your employer may use all or part of the
information in the article for other intra-company use (e.g., training)
• retain patent and trademark rights and rights to any processes or
procedure described in the article
• include the article in full or in part in a thesis or dissertation
(provided that this is not to be published commercially)
• use the article or any part thereof in a printed compilation of your
works, such as collected writings or lecture notes (subsequent to
publication of your article in the journal)
• prepare other derivative works, to extend the article into book-length
form, or to otherwise re-use portions or excerpts in other works, with
full acknowledgement of its original publication in the journal.

	
		

		

		
	
Printer-friendly version <javascript:openPrinterFriendlyPage()>
  Printer-friendly version <javascript:openPrinterFriendlyPage()>

	

		

		
	
	
 Home </wps/find/homepage.cws_home> | Site map
</wps/find/sitemap.cws_home/sitemap> | Privacy policy
</wps/find/privacypolicy.cws_home/privacypolicy> | Terms and Conditions
</wps/find/termsconditions.cws_home/termsconditions> | Feedback
</wps/find/feedbackform.cws_home> | A Reed Elsevier
<http://www.reed-elsevier.com> company 	
 Copyright © 2007 Elsevier B.V. </wps/find/homepage.cws_home> All rights
reserved.

	

